These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 19859562
1. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. Courtin D, Oesterholt M, Huismans H, Kusi K, Milet J, Badaut C, Gaye O, Roeffen W, Remarque EJ, Sauerwein R, Garcia A, Luty AJ. PLoS One; 2009 Oct 27; 4(10):e7590. PubMed ID: 19859562 [Abstract] [Full Text] [Related]
2. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort. Adamou R, Dechavanne C, Sadissou I, d'Almeida T, Bouraima A, Sonon P, Amoussa R, Cottrell G, Le Port A, Theisen M, Remarque EJ, Longacre S, Moutairou K, Massougbodji A, Luty AJF, Nuel G, Migot-Nabias F, Sanni A, Garcia A, Milet J, Courtin D. Malar J; 2019 Jun 11; 18(1):194. PubMed ID: 31185998 [Abstract] [Full Text] [Related]
3. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG. Infect Immun; 2009 Mar 11; 77(3):1165-74. PubMed ID: 19139189 [Abstract] [Full Text] [Related]
4. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA. Infect Immun; 2006 Aug 11; 74(8):4573-80. PubMed ID: 16861644 [Abstract] [Full Text] [Related]
5. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana. Amoah LE, Nuvor SV, Obboh EK, Acquah FK, Asare K, Singh SK, Boampong JN, Theisen M, Williamson KC. Parasit Vectors; 2017 Aug 23; 10(1):395. PubMed ID: 28835262 [Abstract] [Full Text] [Related]
6. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, Tiono AB, Konate AT, Chilengi R, Theisen M, Dodoo D, Remarque E, Bosomprah S, Milligan P, Sirima SB. Infect Immun; 2008 Feb 23; 76(2):759-66. PubMed ID: 18070896 [Abstract] [Full Text] [Related]
7. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran. Rouhani M, Zakeri S, Mehrizi AA, Djadid ND. Malar J; 2015 Feb 05; 14():58. PubMed ID: 25652589 [Abstract] [Full Text] [Related]
8. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P, Bosomprah S, Chilengi R, Osei YD, Akanmori BD, Theisen M. Malar J; 2008 Jul 29; 7():142. PubMed ID: 18664257 [Abstract] [Full Text] [Related]
9. Relationship between malaria incidence and IgG levels to Plasmodium falciparum merozoite antigens in Malian children: impact of hemoglobins S and C. Miura K, Diakite M, Diouf A, Doumbia S, Konate D, Keita AS, Moretz SE, Tullo G, Zhou H, Lopera-Mesa TM, Anderson JM, Fairhurst RM, Long CA. PLoS One; 2013 Jul 29; 8(3):e60182. PubMed ID: 23555917 [Abstract] [Full Text] [Related]
10. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A. Berry AA, Gottlieb ER, Kouriba B, Diarra I, Thera MA, Dutta S, Coulibaly D, Ouattara A, Niangaly A, Kone AK, Traore K, Tolo Y, Mishcherkin V, Soisson L, Diggs CL, Blackwelder WC, Laurens MB, Sztein MB, Doumbo OK, Plowe CV, Lyke KE. Malar J; 2019 Jan 18; 18(1):13. PubMed ID: 30658710 [Abstract] [Full Text] [Related]
11. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. Dodoo D, Atuguba F, Bosomprah S, Ansah NA, Ansah P, Lamptey H, Egyir B, Oduro AR, Gyan B, Hodgson A, Koram KA. Malar J; 2011 May 01; 10():108. PubMed ID: 21529376 [Abstract] [Full Text] [Related]
12. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. Reiling L, Richards JS, Fowkes FJ, Wilson DW, Chokejindachai W, Barry AE, Tham WH, Stubbs J, Langer C, Donelson J, Michon P, Tavul L, Crabb BS, Siba PM, Cowman AF, Mueller I, Beeson JG. PLoS One; 2012 May 01; 7(9):e45253. PubMed ID: 23028883 [Abstract] [Full Text] [Related]
13. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children. Høgh B. Scand J Infect Dis Suppl; 1996 May 01; 102():1-53. PubMed ID: 9060051 [Abstract] [Full Text] [Related]
14. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Soe S, Theisen M, Roussilhon C, Aye KS, Druilhe P. Infect Immun; 2004 Jan 01; 72(1):247-52. PubMed ID: 14688102 [Abstract] [Full Text] [Related]
15. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Taylor RR, Allen SJ, Greenwood BM, Riley EM. Am J Trop Med Hyg; 1998 Apr 01; 58(4):406-13. PubMed ID: 9574783 [Abstract] [Full Text] [Related]
16. Plasmodium falciparum infection and age influence parasite growth inhibition mediated by IgG in Beninese infants. Adamou R, Chénou F, Sadissou I, Sonon P, Dechavanne C, Djilali-Saïah A, Cottrell G, Le Port A, Massougbodji A, Remarque EJ, Luty AJ, Sanni A, Garcia A, Migot-Nabias F, Milet J, Courtin D. Acta Trop; 2016 Jul 01; 159():111-9. PubMed ID: 27001144 [Abstract] [Full Text] [Related]
17. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes. Mbengue B, Fall MM, Varela ML, Loucoubar C, Joos C, Fall B, Niang MS, Niang B, Mbow M, Dieye A, Perraut R. Clin Exp Immunol; 2019 Apr 01; 196(1):86-96. PubMed ID: 30580455 [Abstract] [Full Text] [Related]
18. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Stanisic DI, Fowkes FJ, Koinari M, Javati S, Lin E, Kiniboro B, Richards JS, Robinson LJ, Schofield L, Kazura JW, King CL, Zimmerman P, Felger I, Siba PM, Mueller I, Beeson JG. Infect Immun; 2015 Feb 01; 83(2):646-60. PubMed ID: 25422270 [Abstract] [Full Text] [Related]
19. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria. Perraut R, Varela ML, Joos C, Diouf B, Sokhna C, Mbengue B, Tall A, Loucoubar C, Touré A, Mercereau-Puijalon O. Vaccine; 2017 Dec 04; 35(48 Pt B):6720-6726. PubMed ID: 29042203 [Abstract] [Full Text] [Related]
20. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. Reddy SB, Anders RF, Beeson JG, Färnert A, Kironde F, Berenzon SK, Wahlgren M, Linse S, Persson KE. PLoS One; 2012 Dec 04; 7(2):e32242. PubMed ID: 22363818 [Abstract] [Full Text] [Related] Page: [Next] [New Search]